Moment 22 – Creating meaningful therapies for patients who currently have few or no treatment options.

<p>At Artelo Biosciences, their scientific research and clinical development are advancing their understanding of how lipid-signalling modification, including targeting the receptors of the endocannabinoid system, can have an impact in the treatment of cancer and other serious diseases.  </p> <p> </p> <p>For cancer and its complications such as cancer anorexia-cachexia syndrome, neuropathic pain, anxiety and sleeplessness, they believe their unique platform may lead to meaningful therapies for patients who currently have few or no treatment options.</p> <p> </p> <p>Tune in this Wednesday to hear Andy's story and the amazing work Artelo Biosciences are doing.</p>